News Your Patients Can Use: Boehringer Ingelheim, GoodRx Offer Low Cash Price for Humira Biosimilar
Boehringer Ingelheim and GoodRx are partnering for a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer’s biosimilar to Humira (adalimumab), at a low cash price exclusively on GoodRx. The citrate-free, injectable medication is used to treat or reduce the signs and symptoms of certain autoimmune conditions, such as psoriasis, psoriatic arthritis, hidradenitis suppurativa, rheumatoid arthritis, Crohn’s disease, […]